Short description
Biotech company developing bioprinted tissue therapeutics to transform how we treat disease.
Description
Aspect Biosystems is a biotechnology company developing bioprinted tissue therapeutics to transform how we treat disease. By combining its proprietary microfluidic 3D bioprinting technology, therapeutic cells, and materials science, Aspect is creating a pipeline of allogeneic cell-based tissue therapeutics to replace or repair damaged organ functions. The company is also partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine.
Total funding
$$2020202
Sign in for full access
Location
Vancouver, British Columbia, Canada, North America
Founded on
November 19, 2013
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$34056 - 789030
Sign in for full access
Investors
Noway Youcantaccess, Noaccessforu, Cannot Access, Blurry Noaccess, No Way, Noway Youcantaccess, Noway Youcantaccess, Uh Ohhhh, Cannot Access, Blurry Noaccess, Noaccessforu, Noway Youcantaccess, Noway Youcantaccess, Nopepepe, Absolutely Noaccess, Cannot Access, Absolutely Noaccess, Noaccess, Absolutely Noaccess, Noaccess, Noaccess
Sign in for full access
Founders
Konrad Walus, Sam Wadsworth, Simon Beyer, Tamer Mohamed